当前位置: 首页 > 期刊 > 《糖尿病新世界》 > 2017年第14期
编号:13223378
α—硫辛酸、前列地尔联合甲钴胺治疗糖尿病周围神经病变的疗效观察(3)
http://www.100md.com 2017年7月15日 糖尿病新世界 2017年第14期
     [2] AI Vinik, C Casellini,ML Nevoret.Alternative Quantitative Tools in the Assessment of Diabetic Peripheral and Autonomic Neuropathy[J]. International Review of Neurobiology, 2016,127:235-285.

    [3] Levitt, NS Stansberry KB,Wychanck S,et al. Natural progression of autonomic neuropathy and autonomic function tests in a cohort of IDDM[J].Diabetes Care,1996(19):751-754.

    [4] Dan Wang,Jun-Xia Zhai ,Dian-Wu Liu. Serum folate, vitamin B12 levels and diabetic peripheral neuropathy in type 2 diabetes: A meta-analysis[J].Molecular and Cellular Endoc-rinology,2017(443):72-79.

    [5] Chmeichle AM,Schmelzer JD,Low PA.Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy[J].Diabetes,2003,52(1):165-171.

    [6] Brownlee M. Biochemistry and molecular cell biology of diabetic complica-tions[J]. Nature,2001,414(6865):813-20.

    [7] 凌丹蕓,汤正义,王卫庆.抗氧化剂α-硫辛酸在糖尿病神经病变治疗中的作用[J].世界临床药物,2005,26(12):726-729.

    (收稿日期:2017-06-27), http://www.100md.com(杨轶青)
上一页1 2 3